Shyam K Akula,Allen Y Chen,Jennifer E Neil,Diane D Shao,Alisa Mo,Norma K Hylton,Stephanie DiTroia,Vijay S Ganesh,Richard S Smith,Katherine O'Kane,Rebecca C Yeh,Jack H Marciano,Samantha Kirkham,Connor J Kenny,Janet H T Song,Muna Al Saffar,Francisca Millan,David J Harris,Andrea V Murphy,Kara C Klemp,Stephen R Braddock,Harrison Brand,Isaac Wong,Michael E Talkowski,Anne O'Donnell-Luria,Abbe Lai,Robert Sean Hill,Ganeshwaran H Mochida,Ryan N Doan,A James Barkovich,Edward Yang,Dina Amrom,Eva Andermann,Annapurna Poduri,Christopher A Walsh,Polymicrogyria Genetics Research Network,Bassam Abu-Libdeh,Lihadh Al-Gazali,Edith Alva Moncayo,Eva Anderman,Anna-Kaisa Anttonen,Saunder Barnes,Sara Barnett,Todd Barron,Brenda J Barry,Lina Basel-Vanagaite,Laila Bastaki,Luis Bello-Espinosa,Tawfeg Ben-Omran,Matthew Bernard,Carsten G Bonneman,Blaise Bourgeois,Stephen Brown,Roberto H Caraballo,Gergory Cascino,Michael Clarke,Monika Cohen,Yanick Crow,Bernard Dan,Kira A Dies,William B Dobyns,François Dubeau,Christelle El Achkar,Gregory M Enns,Laurence Faivre,Laura Flores-Sarnat,John Gaitanis,Kuchukhidze Giorgi,Andrew Green,Alan Guberman,Renzo Guerrini,Micheil Innes,Richard Jacobsen,Sebastian Jacquemont,Samir Khalil,Joerg Klepper,Dimitri Kranic,Kalpathy Krishnamoorthy,Anna-Elina Lehesjoki,Dorit Lev,Richard J Leventer,Emily Lisi,Valerie Loik Ramey,Sally Ann Lynch,Laila Mahmoud,David Manchester,David Mandelbaum,Daphna Marom,Deborah Marsden,Mayra Martinez Ojeda,Amira Masri,Livija Medne,Denis Melanson,David T Miller,Anna Minster,Edward Neilan,Dang Khoa Nguyen,Heather E Olson,Ignacio Pascual-Castroviejo,Philip L Pearl,Daniela Pilz,Nada Quercia,Salmo Raskin,Miriam Regev,Lance Rodan,Cynthia Rooney,Michael Rutlin,Mustafa Sahin,Mustafa A Salih,Pierre Sarda,Harvey B Sarnat,Ingrid Scheffer,Joseph Shieh,Sharon E Smith,Janet S Soul,Siddharth Srivastava,Laszlo Sztriha,Donatella Tampieri,John Tolmie,Meral Topçu,Eugen Trinka,John Tsai,Jack Tsao,Sheila Unger,Iris Unterberger,Goekhan Uyanik,Kette Valente,Thomas Voit,Louise Wilson,Grace Yoon

Abstract:Importance: Polymicrogyria is the most commonly diagnosed cortical malformation and is associated with neurodevelopmental sequelae including epilepsy, motor abnormalities, and cognitive deficits. Polymicrogyria frequently co-occurs with other brain malformations or as part of syndromic diseases. Past studies of polymicrogyria have defined heterogeneous genetic and nongenetic causes but have explained only a small fraction of cases. Objective: To survey germline genetic causes of polymicrogyria in a large cohort and to consider novel polymicrogyria gene associations. Design, setting, and participants: This genetic association study analyzed panel sequencing and exome sequencing of accrued DNA samples from a retrospective cohort of families with members with polymicrogyria. Samples were accrued over more than 20 years (1994 to 2020), and sequencing occurred in 2 stages: panel sequencing (June 2015 to January 2016) and whole-exome sequencing (September 2019 to March 2020). Individuals seen at multiple clinical sites for neurological complaints found to have polymicrogyria on neuroimaging, then referred to the research team by evaluating clinicians, were included in the study. Targeted next-generation sequencing and/or exome sequencing were performed on probands (and available parents and siblings) from 284 families with individuals who had isolated polymicrogyria or polymicrogyria as part of a clinical syndrome and no genetic diagnosis at time of referral from clinic, with sequencing from 275 families passing quality control. Main outcomes and measures: The number of families in whom genetic sequencing yielded a molecular diagnosis that explained the polymicrogyria in the family. Secondarily, the relative frequency of different genetic causes of polymicrogyria and whether specific genetic causes were associated with co-occurring head size changes were also analyzed. Results: In 32.7% (90 of 275) of polymicrogyria-affected families, genetic variants were identified that provided satisfactory molecular explanations. Known genes most frequently implicated by polymicrogyria-associated variants in this cohort were PIK3R2, TUBB2B, COL4A1, and SCN3A. Six candidate novel polymicrogyria genes were identified or confirmed: de novo missense variants in PANX1, QRICH1, and SCN2A and compound heterozygous variants in TMEM161B, KIF26A, and MAN2C1, each with consistent genotype-phenotype relationships in multiple families. Conclusions and relevance: This study's findings reveal a higher than previously recognized rate of identifiable genetic causes, specifically of channelopathies, in individuals with polymicrogyria and support the utility of exome sequencing for families affected with polymicrogyria.

Ep098: Exome Sequencing of >500 Individuals with Brain Malformation Phenotypes Reveals Marked Genetic Heterogeneity

Whole-exome Sequencing Identifies Recessive WDR62 Mutations in Severe Brain Malformations.

Diagnostic Yield and Novel Candidate Genes for Neurodevelopmental Disorders by Exome Sequencing in an Unselected Cohort with Microcephaly

Utility of genome sequencing in exome‐negative pediatric patients with neurodevelopmental phenotypes

Comprehensive multi-omic profiling of somatic mutations in malformations of cortical development

Exome Sequencing and the Identification of New Genes and Shared Mechanisms in Polymicrogyria

Genetic and phenotypic analysis of 225 Chinese children with developmental delay and/or intellectual disability using whole-exome sequencing

Comprehensive whole-genome sequence analyses provide insights into the genomic architecture of cerebral palsy

Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation.

Exploring unsolved cases of lissencephaly spectrum: integrating exome and genome sequencing for higher diagnostic yield

Exome sequencing improves the molecular diagnostics of paediatric unexplained neurodevelopmental disorders

Exome sequencing in 90 children with developmental delay: a single-center experience

Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management.

Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions

X-exome Sequencing of 405 Unresolved Families Identifies Seven Novel Intellectual Disability Genes.

Somatic Mutations in Cerebral Cortical Malformations.

Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders

Exome sequencing reveals genetic heterogeneity and clinically actionable findings in children with cerebral palsy

Clinical use of whole exome sequencing in children with developmental delay/intellectual disability

Exome sequencing identifies molecular diagnosis in children with drug-resistant epilepsy

Marked Yield of Re-Evaluating Phenotype and Exome/target Sequencing Data in 33 Individuals with Intellectual Disabilities